1. Home
  2. GNFT vs SFST Comparison

GNFT vs SFST Comparison

Compare GNFT & SFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • SFST
  • Stock Information
  • Founded
  • GNFT 1999
  • SFST 1999
  • Country
  • GNFT France
  • SFST United States
  • Employees
  • GNFT N/A
  • SFST N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • SFST Major Banks
  • Sector
  • GNFT Health Care
  • SFST Finance
  • Exchange
  • GNFT Nasdaq
  • SFST Nasdaq
  • Market Cap
  • GNFT 249.0M
  • SFST N/A
  • IPO Year
  • GNFT 2019
  • SFST 1999
  • Fundamental
  • Price
  • GNFT $6.06
  • SFST $35.38
  • Analyst Decision
  • GNFT Strong Buy
  • SFST Buy
  • Analyst Count
  • GNFT 1
  • SFST 1
  • Target Price
  • GNFT $13.00
  • SFST $44.00
  • AVG Volume (30 Days)
  • GNFT 21.7K
  • SFST 19.3K
  • Earning Date
  • GNFT 09-19-2024
  • SFST 10-21-2024
  • Dividend Yield
  • GNFT N/A
  • SFST N/A
  • EPS Growth
  • GNFT N/A
  • SFST N/A
  • EPS
  • GNFT 0.47
  • SFST 1.70
  • Revenue
  • GNFT $86,225,222.00
  • SFST $88,995,000.00
  • Revenue This Year
  • GNFT $155.44
  • SFST N/A
  • Revenue Next Year
  • GNFT N/A
  • SFST $13.55
  • P/E Ratio
  • GNFT $11.74
  • SFST $20.10
  • Revenue Growth
  • GNFT 175.45
  • SFST N/A
  • 52 Week Low
  • GNFT $2.97
  • SFST $24.98
  • 52 Week High
  • GNFT $6.08
  • SFST $39.36
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 69.91
  • SFST 69.23
  • Support Level
  • GNFT $5.41
  • SFST $33.88
  • Resistance Level
  • GNFT $5.84
  • SFST $34.61
  • Average True Range (ATR)
  • GNFT 0.30
  • SFST 0.65
  • MACD
  • GNFT 0.04
  • SFST 0.10
  • Stochastic Oscillator
  • GNFT 98.03
  • SFST 96.44

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: